Synlait Secures Covenant Relief and Facility Extensions Ahead of Asset Sale

An announcement from Synlait Milk Ltd. ( (AU:SM1) ) is now available.

Synlait Milk has secured amendments, waivers and extensions to its syndicated banking facilities, easing near-term covenant pressures as it works through a challenging half-year performance and awaits proceeds from the sale of its North Island assets. The changes include deferring a $50 million step-down in its main revolving credit line, waiving and revising certain EBITDA, leverage and interest cover tests, and aiming to extend the maturity of a related facility, collectively providing additional financial flexibility and breathing room for lenders and stakeholders ahead of the expected April asset sale.

These facility adjustments reduce the risk of covenant breaches and support Synlait’s liquidity as it navigates a transition period in its capital structure. For investors, creditors and suppliers, the move signals continued lender support while the company restructures its asset base and works to stabilise earnings, although one element of the maturity extension still requires approval from a remaining lender.

The most recent analyst rating on (AU:SM1) stock is a Hold with a A$0.72 price target. To see the full list of analyst forecasts on Synlait Milk Ltd. stock, see the AU:SM1 Stock Forecast page.

More about Synlait Milk Ltd.

Synlait Milk Limited is a New Zealand-based dairy company focused on processing milk and producing value-added dairy ingredients. It supplies products for domestic and international markets, including ingredients for consumer and infant nutrition, leveraging large-scale processing facilities in Canterbury and previously in the North Island.

Average Trading Volume: 23,243

Technical Sentiment Signal: Sell

Current Market Cap: A$244M

For an in-depth examination of SM1 stock, go to TipRanks’ Overview page.